Representative Wheat germ agglutinin-stained images and myocyte cross-sectional area show that LCAC supplementation exacerbates cardiac hypertrophy 7 days after reperfusion injury, whereas ETO treatment reduces myocardial hypertrophy (Figures 7H and 7I). The gene discussed is RUNX1T1; the disease is cardiac hypertrophy.